Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04696055
Brief Title: Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors

First Submitted : January 4, 2021
First Submitted that Met QC Criteria : January 4, 2021
First Posted : January 6, 2021

Last Update Submitted that Met QC Criteria : September 28, 2021
Last Update Posted : September 29, 2021